News | CT Angiography (CTA) | January 11, 2024

Photon-Counting Detector CT Virtual Monoenergetic Images for Coronary Artery Stenosis Open configuration options

82-year-old man with calcified stenosis in left main artery who underwent coronary CTA by PCD CT

82-year-old man with calcified stenosis in left main artery who underwent coronary CTA by PCD CT. Curved multiplanar reformatted images at varying virtual monoenergetic imaging (VMI) levels (40-140 keV) show stenosis at each level. Percent diameter stenosis (PDS) decreased from 92.5% at 40 keV to 53.1% at 140 keV. Extent of calcium blooming artifacts decreased from 100.0% at 40 keV to 72.3% at 140 keV.


January 11, 2024 — According to the American Journal of Roentgenology (AJR), photon-counting detector (PCD) CT with virtual monoenergetic imaging (VMI) reconstruction can help overcome present limitations in stenosis quantification on coronary CTA.

“When performing coronary CTA by PCD CT, the selection of VMI level influences stenosis assessment in calcified and mixed plaque, thereby potentially impacting clinical decision-making,” wrote corresponding author Tilman Emrich, MD, from the department of diagnostic and interventional radiology at Germany’s University Medical Center in Mainz.

In this AJR accepted manuscript, a phantom containing two custom-made vessels (25% and 50% stenoses) underwent PCD CT acquisitions without and with simulated cardiac motion. A retrospective analysis was performed of 33 patients (7 female, 26 male; mean age, 71 years; 64 coronary artery stenoses) who underwent coronary CTA by PCD CT followed by invasive coronary angiography (ICA). Scans were reconstructed at nine VMI levels (40–140 keV). Percentage diameter stenosis was measured, and bias was determined from the ground-truth stenosis percentage in the phantom and ICA-derived quantitative coronary angiography measurements in patients. Extent of blooming artifacts was measured in the phantom and in calcified and mixed plaques in patients.

Ultimately, for coronary CTA performed by PCD CT, stenosis percentage and calcium blooming artifacts decreased with increasing VMI level in calcified and mixed plaque. Stenosis measurement exhibited lowest bias, using invasive angiography as reference, at 100, 140, and 40 keV for calcified, mixed, and non-calcified plaque, respectively.

“To our knowledge,” Emrich et al. added, “this study is the first in vivo study to investigate the influence of different VMI levels on stenosis quantification of PCD CT in comparison with ICA as the reference standard.”

For more information: www.arrs.org


Related Content

News | Cardiac Imaging

March 18, 2026 — Circle Cardiovascular Imaging (Circle CVI) has announced the expansion of its cvi42 cardiovascular ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 19, 2026 — Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 16, 2026 — The American Society for Preventive Cardiology (ASPC) will host its 2026 Virtual Imaging Symposium, a ...

Home March 17, 2026
Home
Feature | Cardiac Imaging

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

Home March 13, 2026
Home
News | Cardiac Imaging

March 6, 2026 — Building on its leadership in cardiac MR, Philips has received FDA 510(k) clearance for SmartHeart, an ...

Home March 09, 2026
Home
News | Cardiac Imaging

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Home February 26, 2026
Home
News | Cardiac Imaging

Feb. 13, 2026 — Conavi Medical Corp. recently highlighted the publication of new peer-reviewed research titled “Deep ...

Home February 16, 2026
Home
News | Cardiac Imaging

Jan. 27. 2026 — Circle Cardiovascular Imaging Inc. has announced the release of cvi42 v6.4, the latest version of its ...

Home January 28, 2026
Home
News | Cardiac Imaging

Jan. 6, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced FDA clearance to expand its ...

Home January 16, 2026
Home
News | Cardiac Imaging

Jan. 12, 2026 — YorLabs, Inc., a medical technology company providing next-generation intracardiac imaging solutions for ...

Home January 13, 2026
Home
Subscribe Now